Owens & Minor (OMI) Stock Price, News & Analysis

Company Overview

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segment includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.

Key Stats

• Today's Range: $6.47 to $6.73
• 50-Day Range: $6.45 to $9.27
• 52-Week Range: $6.07 to $17.78
• Volume: 111,222 shs
• Average Volume: 1.14 million shs
• Market Capitalization: $497.60 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $12.50
• Consensus Rating: Hold

Owens & Minor Stock Analysis - MarketRank™

Owens & Minor scored higher than 94% of companies evaluated by MarketBeat, and ranked 48th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

Owens & Minor has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 2 buy ratings, 2 hold ratings, and 2 sell ratings.

Amount of Analyst Coverage

Owens & Minor has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.8 / 5
• Proj. Earnings Growth: 16.56%

Earnings Growth

Earnings for Owens & Minor are expected to grow by 16.56% in the coming year, from $1.51 to $1.76 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Owens & Minor is -10.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Owens & Minor is -10.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Owens & Minor has a PEG Ratio of 0.20. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Owens & Minor has a P/B Ratio of 0.54. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.62% of the float of Owens & Minor has been sold short.

Short Interest Ratio / Days to Cover

Owens & Minor has a short interest ratio ("days to cover") of 4.2.

Change versus previous month

Short interest in Owens & Minor has recently increased by 1.71%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Owens & Minor does not currently pay a dividend.

Dividend Growth

Owens & Minor does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 3.9 / 5
• Environmental Score: -1.52

Percentage of Shares Shorted

9.62% of the float of Owens & Minor has been sold short.

Short Interest Ratio / Days to Cover

Owens & Minor has a short interest ratio ("days to cover") of 4.2.

Change versus previous month

Short interest in Owens & Minor has recently increased by 1.71%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 1.10

News Sentiment

Owens & Minor has a news sentiment score of 1.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Owens & Minor this week, compared to 6 articles on an average week.

Search Interest

2 people have searched for OMI on MarketBeat in the last 30 days.

MarketBeat Follows

Only 1 people have added Owens & Minor to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Owens & Minor insiders have bought more of their company's stock than they have sold. Specifically, they have bought $24,495,308.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 3.69% of the stock of Owens & Minor is held by insiders.

Percentage Held by Institutions

98.04% of the stock of Owens & Minor is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

OMI Stock Analysis - Frequently Asked Questions

How have OMI shares performed this year?

Owens & Minor's stock was trading at $13.07 at the start of the year. Since then, OMI stock has decreased by 50.2% and is now trading at $6.5150.
View the best growth stocks for 2025 here.

How were Owens & Minor's earnings last quarter?

Owens & Minor, Inc. (NYSE:OMI) posted its quarterly earnings data on Saturday, May, 10th. The company reported $0.23 EPS for the quarter, beating the consensus estimate of $0.20 by $0.03. Owens & Minor's revenue for the quarter was up .7% compared to the same quarter last year.
Read the conference call transcript.

Is Owens & Minor doing a stock buyback?

Owens & Minor's Board of Directors approved a stock buyback plan on Friday, February 28th 2025, which allows the company to buy back $100,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 13.6% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's board of directors believes its shares are undervalued.

Does Owens & Minor have any subsidiaries?

The following companies are subsidiaries of Owens & Minor: Halyard Health - S&IP, Byram Healthcare Centers, ArcRoyal, Medical Action Industries, Movianto, The Burrows Company, McKesson's Acute-Care Medical, and more.

Who are Owens & Minor's major shareholders?

Owens & Minor's top institutional investors include Coliseum Capital Management LLC (13.75%), Vanguard Group Inc. (11.85%), Charles Schwab Investment Management Inc. (3.56%) and Invesco Ltd. (2.22%). Insiders that own company stock include Coliseum Capital Management, L, Edward A Pesicka, Jeffrey T Jochims, Perry A Bernocchi, Jonathan A Leon, Michael Wayne Lowry, Snehashish Sarkar, Heath H Galloway, Alexander J Bruni, Robert J Henkel and Mark A Beck.
View institutional ownership trends.

How do I buy shares of Owens & Minor?

Shares of OMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Owens & Minor own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Owens & Minor investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

• Last Earnings: 5/10/2025
• Today: 5/29/2025
• Next Earnings (Estimated): 8/01/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical & hospital equipment
• Sub-Industry: Health Care Distributors
• Current Symbol: NYSE:OMI
• CIK: 75252
• Web: www.owens-minor.com
• Phone: (804) 723-7000
• Fax: 804-723-7100
• Employees: 22,500
• Year Founded: 1882

Price Target and Rating

• Average Stock Price Target: $12.50
• High Stock Price Target: $16.00
• Low Stock Price Target: $10.00
• Potential Upside/Downside: +91.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 6 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($4.75)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 4.31
• P/E Growth: 0.2
• Net Income: -$41.30 million
• Net Margins: -0.46%
• Pretax Margin: -0.34%
• Return on Equity: 14.60%
• Return on Assets: 2.51%

Debt

• Debt-to-Equity Ratio: 2.11
• Current Ratio: 1.09
• Quick Ratio: 0.45

Sales & Book Value

• Annual Sales: $10.72 billion
• Price / Sales: 0.05
• Cash Flow: $5.21 per share
• Price / Cash Flow: 1.25
• Book Value: $12.08 per share
• Price / Book: 0.54

Miscellaneous

• Outstanding Shares: 77,255,000
• Free Float: 74,341,000
• Market Cap: $503.32 million
• Optionable: Optionable
• Beta: 1.38